1. Home
  2. REFR vs RPID Comparison

REFR vs RPID Comparison

Compare REFR & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REFR
  • RPID
  • Stock Information
  • Founded
  • REFR 1965
  • RPID 2006
  • Country
  • REFR United States
  • RPID United States
  • Employees
  • REFR N/A
  • RPID N/A
  • Industry
  • REFR Multi-Sector Companies
  • RPID Medical Specialities
  • Sector
  • REFR Miscellaneous
  • RPID Health Care
  • Exchange
  • REFR Nasdaq
  • RPID Nasdaq
  • Market Cap
  • REFR N/A
  • RPID 138.9M
  • IPO Year
  • REFR N/A
  • RPID 2021
  • Fundamental
  • Price
  • REFR $1.62
  • RPID $3.40
  • Analyst Decision
  • REFR
  • RPID Buy
  • Analyst Count
  • REFR 0
  • RPID 1
  • Target Price
  • REFR N/A
  • RPID $8.00
  • AVG Volume (30 Days)
  • REFR 34.3K
  • RPID 85.5K
  • Earning Date
  • REFR 07-31-2025
  • RPID 08-01-2025
  • Dividend Yield
  • REFR N/A
  • RPID N/A
  • EPS Growth
  • REFR N/A
  • RPID N/A
  • EPS
  • REFR N/A
  • RPID N/A
  • Revenue
  • REFR $1,581,929.00
  • RPID $29,645,000.00
  • Revenue This Year
  • REFR N/A
  • RPID $18.54
  • Revenue Next Year
  • REFR N/A
  • RPID $20.55
  • P/E Ratio
  • REFR N/A
  • RPID N/A
  • Revenue Growth
  • REFR 62.28
  • RPID 28.36
  • 52 Week Low
  • REFR $0.93
  • RPID $0.58
  • 52 Week High
  • REFR $2.39
  • RPID $4.04
  • Technical
  • Relative Strength Index (RSI)
  • REFR 42.18
  • RPID 53.94
  • Support Level
  • REFR $1.57
  • RPID $3.41
  • Resistance Level
  • REFR $1.84
  • RPID $3.62
  • Average True Range (ATR)
  • REFR 0.12
  • RPID 0.23
  • MACD
  • REFR -0.04
  • RPID -0.03
  • Stochastic Oscillator
  • REFR 14.50
  • RPID 60.76

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Share on Social Networks: